Literature DB >> 15194756

Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats.

Jean-Charles Paterna1, Joram Feldon, Hansruedi Büeler.   

Abstract

We compared the transduction efficiencies and tropisms of titer-matched recombinant adeno-associated viruses (rAAV) derived from serotypes 2 and 5 (rAAV-2 and rAAV-5, respectively) within the rat nigrostriatal system. The two serotypes (expressing enhanced green fluorescent protein [EGFP]) were delivered by stereotaxic surgery into the same animals but different hemispheres of the striatum (STR), the substantia nigra (SN), or the medial forebrain bundle (MFB). While both serotypes transduced neurons effectively within the STR, rAAV-5 resulted in a much larger EGFP-expressing area than did rAAV-2. However, neurons transduced with rAAV-2 vectors expressed higher levels of EGFP. Consistent with this result, EGFP-positive projections emanating from transduced striatal neurons covered a larger area of the SN pars reticulata (SNr) after striatal delivery of rAAV-5, but EGFP levels in fibers of the SNr were higher after striatal injection of rAAV-2. We also compared the potentials of the two vectors for retrograde transduction and found that striatal delivery of rAAV-5 resulted in significantly more transduced dopaminergic cell bodies within the SN pars compacta and ventral tegmental area. Similarly, EGFP-transduced striatal neurons were detected only after nigral delivery of rAAV-5. Furthermore, we demonstrate that after striatal AAV-5 vector delivery, the transduction profiles were stable for as long as 9 months. Finally, although we did not target the hippocampus directly, efficient and widespread transduction of hippocampal neurons was observed after delivery of rAAV-5, but not rAAV-2, into the MFB.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194756      PMCID: PMC421643          DOI: 10.1128/JVI.78.13.6808-6817.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer.

Authors:  Deniz Kirik; Biljana Georgievska; Corinna Burger; Christian Winkler; Nicholas Muzyczka; Ronald J Mandel; Anders Bjorklund
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

2.  Recombinant adeno-associated virus serotypes 2- and 5-mediated gene transfer in the mammalian brain: quantitative analysis of heparin co-infusion.

Authors:  Mihail Y Mastakov; Kristin Baer; Robert M Kotin; Matthew J During
Journal:  Mol Ther       Date:  2002-04       Impact factor: 11.454

Review 3.  Recombinant adeno-associated virus vector design and gene expression in the mammalian brain.

Authors:  Jean-Charles Paterna; Hansruedi Büeler
Journal:  Methods       Date:  2002-10       Impact factor: 3.608

4.  Dopaminergic neurons protected from degeneration by GDNF gene therapy.

Authors:  D L Choi-Lundberg; Q Lin; Y N Chang; Y L Chiang; C M Hay; H Mohajeri; B L Davidson; M C Bohn
Journal:  Science       Date:  1997-02-07       Impact factor: 47.728

5.  Measurements of vector-derived neurotrophic factor and green fluorescent protein levels in the brain.

Authors:  Ronald L Klein; Mary E Hamby; Christopher F Sonntag; William J Millard; Michael A King; Edwin M Meyer
Journal:  Methods       Date:  2002-10       Impact factor: 3.608

Review 6.  Adeno-associated virus vectors for gene transfer to the brain.

Authors:  Takashi Okada; Tatsuya Nomoto; Kuniko Shimazaki; Wang Lijun; Yanyan Lu; Takashi Matsushita; Hiroaki Mizukami; Masashi Urabe; Yutaka Hanazono; Akihiro Kume; Shin-ichi Muramatsu; Imaharu Nakano; Keiya Ozawa
Journal:  Methods       Date:  2002-10       Impact factor: 3.608

7.  Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra.

Authors:  Ronald L Klein; Michael A King; Mary E Hamby; Edwin M Meyer
Journal:  Hum Gene Ther       Date:  2002-03-20       Impact factor: 5.695

8.  Dose and promoter effects of adeno-associated viral vector for green fluorescent protein expression in the rat brain.

Authors:  Ronald L Klein; Mary E Hamby; Yan Gong; Aaron C Hirko; Samuel Wang; Jeffrey A Hughes; Michael A King; Edwin M Meyer
Journal:  Exp Neurol       Date:  2002-07       Impact factor: 5.330

9.  Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase.

Authors:  M J During; J R Naegele; K L O'Malley; A I Geller
Journal:  Science       Date:  1994-11-25       Impact factor: 47.728

10.  Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy.

Authors:  Guang-Ping Gao; Mauricio R Alvira; Lili Wang; Roberto Calcedo; Julie Johnston; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-21       Impact factor: 11.205

View more
  39 in total

Review 1.  Parkinson's disease: gene therapies.

Authors:  Philippe G Coune; Bernard L Schneider; Patrick Aebischer
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

2.  Serotype-dependent transduction efficiencies of recombinant adeno-associated viral vectors in monkey neocortex.

Authors:  Annelies Gerits; Pascaline Vancraeyenest; Samme Vreysen; Marie-Eve Laramée; Annelies Michiels; Rik Gijsbers; Chris Van den Haute; Lieve Moons; Zeger Debyser; Veerle Baekelandt; Lutgarde Arckens; Wim Vanduffel
Journal:  Neurophotonics       Date:  2015-10-01       Impact factor: 3.593

3.  Lentiviral-mediated knock-down of GD3 synthase protects against MPTP-induced motor deficits and neurodegeneration.

Authors:  Anandh Dhanushkodi; Yi Xue; Emily E Roguski; Yun Ding; Shannon G Matta; Detlef Heck; Guo-Huang Fan; Michael P McDonald
Journal:  Neurosci Lett       Date:  2018-11-01       Impact factor: 3.046

4.  Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons.

Authors:  Matthew R J Mason; Erich M E Ehlert; Ruben Eggers; Chris W Pool; Stephan Hermening; Angelina Huseinovic; Eric Timmermans; Bas Blits; Joost Verhaagen
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

5.  Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins.

Authors:  Ronald L Klein; Robert D Dayton; Nancy J Leidenheimer; Karen Jansen; Todd E Golde; Richard M Zweig
Journal:  Mol Ther       Date:  2005-12-01       Impact factor: 11.454

6.  Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, and 9 in rat neurons and glia in vitro.

Authors:  Douglas B Howard; Kathleen Powers; Yun Wang; Brandon K Harvey
Journal:  Virology       Date:  2007-11-26       Impact factor: 3.616

7.  Transgene expression in target-defined neuron populations mediated by retrograde infection with adeno-associated viral vectors.

Authors:  Markus Rothermel; Daniela Brunert; Christine Zabawa; Marta Díaz-Quesada; Matt Wachowiak
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

Review 8.  Progress in transduction of cerebellar Purkinje cells in vivo using viral vectors.

Authors:  Hirokazu Hirai
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

9.  Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates.

Authors:  Hemraj B Dodiya; Tomas Bjorklund; James Stansell; Ronald J Mandel; Deniz Kirik; Jeffrey H Kordower
Journal:  Mol Ther       Date:  2009-09-22       Impact factor: 11.454

10.  AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease.

Authors:  Nicholas R Franich; Helen L Fitzsimons; Dahna M Fong; Matthias Klugmann; Matthew J During; Deborah Young
Journal:  Mol Ther       Date:  2008-03-25       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.